RENOVÓ Biologics
RENOVÓ
Shop
Human umbilical cord–derived biological formulations. US sourced. Full pathogen screening. COA on every batch.
I
Vesicle-Mediated Signalling
Exosomes
Membrane-bound extracellular vesicles restoring the biological signals the body has progressively lost over time.
EXO-90
Consumer & Clinical
Endothelial · Systemic
EXO-90 — Exosomes · Endothelial · Systemic
Exosomes are membrane-bound extracellular vesicles that carry protected biological information...
$1,500.00
II
Structural Matrix · Clinical Only
Wharton's Jelly
The connective tissue matrix of the umbilical cord. Restores the extracellular environment in which cellular activity occurs. Clinical use only.
WJ-75
Clinical Only
Structural · Broad Distribution
70 mg de gelatina Wharton nanonizada pura, que contiene los precursores de colágeno naturales del cuerpo y factores de crecimiento para ...
Apply for Clinical Access
WJ-95
Clinical Only
Concentrated · Small Joints
WJ-95 — Wharton’s Jelly · Concentrated Matrix
Wharton’s jelly is the connective tissue matrix of the human umbilical cord — rich in hyalu...
Apply for Clinical Access
WJ-300
Clinical Only
Maximum Volume · Expanded Environments
WJ-300 — Wharton’s Jelly · Maximum Volume
Wharton’s jelly is the connective tissue matrix of the human umbilical cord — rich in hyaluroni...
Apply for Clinical Access
III
Soluble Signal Environment · Clinical Only
Conditioned Media
The complete soluble secretome providing immediate ambient factor availability. Clinical use only.
CM-1
Clinical Only
Baseline Soluble Signal Environment
CM-1 — Baseline Conditioned Media
Conditioned media is the soluble secretome — the complete spectrum of growth factors, cytokines, and si...
Apply for Clinical Access
CM-2
Clinical Only
Expanded Soluble Signal Environment
CM-2 — Expanded Conditioned Media
Conditioned media is the soluble secretome — the complete spectrum of growth factors, cytokines, and si...
Apply for Clinical Access
Clinical Partners
Verified clinical partners gain access to the full RENOVÓ portfolio including EXO-180, the complete Wharton's Jelly line, Conditioned Media, and the clinical peptide portfolio at clinical pricing.